Gene · 3276
Papers2,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Decoding the Therapeutic Implications of the ERα Stability and Subcellular Distribution in Breast Cancer. | Front Endocrinol (Lausanne) | 2022 | 35498431 | PubTator, text mining | PubMed |
| Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy. | Front Immunol | 2022 | 35493527 | PubTator, text mining | PubMed |
Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach. | J Med Chem | 2022 | 35482954 | PubTator, text mining | PubMed |
| Loss of METTL3 attenuates blastic plasmacytoid dendritic cell neoplasm response to PRMT5 inhibition via IFN signaling. | Blood Adv | 2022 | 35482445 | PubTator, text mining | PubMed |
| PRKDC promotes hepatitis B virus transcription through enhancing the binding of RNA Pol II to cccDNA. | Cell Death Dis | 2022 | 35468873 | PubTator, text mining | PubMed |
| Aryl Hydrocarbon Receptor: From Homeostasis to Tumor Progression. | Front Cell Dev Biol | 2022 | 35465323 | PubTator, text mining | PubMed |
| Epigenetics and Testicular Cancer: Bridging the Gap Between Fundamental Biology and Patient Care. | Front Cell Dev Biol | 2022 | 35465311 | PubTator, text mining | PubMed |
| STAT1 and Its Crucial Role in the Control of Viral Infections. | Int J Mol Sci | 2022 | 35456913 | PubTator, text mining | PubMed |
| Eltrombopag as an Allosteric Inhibitor of the METTL3-14 Complex Affecting the m6A Methylation of RNA in Acute Myeloid Leukemia Cells. | Pharmaceuticals (Basel) | 2022 | 35455436 | PubTator, text mining | PubMed |
| Regulation of ZEB1 Function and Molecular Associations in Tumor Progression and Metastasis. | Cancers (Basel) | 2022 | 35454770 | PubTator, text mining | PubMed |
| Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach. | Cancers (Basel) | 2022 | 35454765 | PubTator, text mining | PubMed |
| Integrated In Silico Analyses Identify PUF60 and SF3A3 as New Spliceosome-Related Breast Cancer RNA-Binding Proteins. | Biology (Basel) | 2022 | 35453681 | PubTator, text mining | PubMed |
| HIV-1-Mediated Acceleration of Oncovirus-Related Non-AIDS-Defining Cancers. | Biomedicines | 2022 | 35453518 | PubTator, text mining | PubMed |
| SGPL1 stimulates VPS39 recruitment to the mitochondria in MICU1 deficient cells. | Mol Metab | 2022 | 35452878 | PubTator, text mining | PubMed |
| Integrative Single-Cell RNA-Seq and ATAC-Seq Analysis of Mesenchymal Stem/Stromal Cells Derived from Human Placenta. | Front Cell Dev Biol | 2022 | 35450295 | PubTator, text mining | PubMed |
| Epigenetic modification regulates tumor progression and metastasis through EMT (Review). | Int J Oncol | 2022 | 35445731 | PubTator, text mining | PubMed |
| A novel screening strategy to identify histone methyltransferase inhibitors reveals a crosstalk between DOT1L and CARM1. | RSC Chem Biol | 2022 | 35441144 | PubTator, text mining | PubMed |
| Lysine methyltransferase inhibitors: where we are now. | RSC Chem Biol | 2022 | 35441141 | PubTator, text mining | PubMed |
| Analogs of S-Adenosyl-L-Methionine in Studies of Methyltransferases. | Mol Biol | 2022 | 35440827 | PubTator, text mining | PubMed |
| Maintaining Transcriptional Specificity Through Mitosis. | Annu Rev Genomics Hum Genet | 2022 | 35440147 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3276/papers?page=38